Low molecular weight dextran in systemic sclerosis

Holti, G
February 1971
British Medical Journal;2/13/1971, Vol. 1 Issue 5745, p405
Academic Journal
No abstract available.


Related Articles

  • Low molecular weight dextran: a continuing cause of acute renal failure. Feest, T.G. // British Medical Journal;11/27/1976, Vol. 2 Issue 6047, p1300 

    Examines the effect of low molecular weight dextran on the development of acute renal failure. Evaluation of the nephrotoxicity of the drug; Filtration of dextran in the glomerulus; Accumulation of dextran in proximal tubular cells.

  • Stenting a downstream, distal endarterectomy. Sherman, Roger W.; H.D.B. // Cortlandt Forum;6/25/95, Vol. 8 Issue 6, p73 

    Reports on the use of stents in distal endarterectomy. Opening of the anastomotic site; Use of postoperative heparin or low-molecular-weight dextran.

  • Iron dextran.  // Reactions Weekly;Jul2015, Vol. 1561 Issue 1, p106 

    An abstract of the article "Intravenous low molecular weight iron dextran in children with iron deficiency anemia unresponsive to oral iron," by E. S. Plummer and colleagues is presented.

  • Is it the end for high-molecular-weight iron dextran?  // Reactions Weekly;7/14/2007, Issue 1160, p3 

    The article focuses on adverse effects associated with the use of high-molecular-weight iron dextran in clinical medicine. According to U.S. researchers Michael Auerbach and George M. Rodgers, many specialists are ignorant about the side effects of using parenteral iron and high-molecular-weight...

  • Combined dexamethasone and low-molecular-weight dextran in acute brain infarction: double-blind study. Kaste, Markku; Fogelholm, Rainer; Waltimo, Olli // British Medical Journal;12/11/1976, Vol. 2 Issue 6049, p1409 

    Examines the effects of combined dexamethasone and low-molecular-weight dextran on acute brain infarction. Improvement of the neurological state and mobility; Occurrence of reversible psychotic episode; Presence of deep vein thrombosis in legs.

  • Partitioning of charged and neutral dextran-dye derivatives in biphasic cellulose nanocrystal suspensions. Beck-Candanedo, Stephanie; Viet, David; Gray, Derek G. // Canadian Journal of Chemistry;Jun2008, Vol. 86 Issue 6, p503 

    The partitioning behaviour of dye-labeled dextrans of high molecular weight in aqueous suspensions of native cellulose nanocrystals was studied. Cellulose concentrations lie in the isotropic–nematic coexistence region. Blue dextrans of various molecular weights and degrees of substitution...

  • A rapid renal clearance methodology for dextran. Leypoldt, John K.; Frigon, Ronald P.; DeVore, Karl W.; Henderson, Lee W. // Kidney International;Mar1987, Vol. 31 Issue 3, p855 

    Introduces an alternative approach for the administration of dextrans for glomerular transport. Advantages of administering dextrans intravenously; Use of high performance gel permeation chromatography for characterizing the molecular weight distribution of neutral dextran; Efficacy of the new...

  • The safety of accelerated infusion versus standard rate infusion of low-molecular-weight iron dextran in patients with chronic kidney disease. Sinha, Smeeta; Chiu, Diana Y. Y.; Peebles, George; Kolakkat, Shabeer; Lamerton, Elizabeth; Fenwick, Sean; Kalra, Philip A. // Nephrology Dialysis Transplantation;Oct2009, Vol. 2 Issue 5, p432 

    The article presents a study which evaluates the safety of adopting an accelerated regimen for the administration of total dose infection (TDI) low-molecular-weight iron dextran. The results of the study show the safety of the accelerated rate of low-molecular-weight iron dextran infusion as a...

  • AN OVER VIEW: MICROSPHERES AS A NASAL DRUG DELIVERY SYSTEM. Chaudhari, Amol; Jadhav, K. R.; Kadam, V. J. // International Journal of Pharmaceutical Sciences Review & Resear;Nov2010, Vol. 5 Issue 1, p8 

    All types of microspheres that have been used as nasal drug delivery systems are water-insoluble but absorb water into the sphere's matrix, resulting in swelling of the spheres and the formation of a gel. The building materials in the microspheres have been starch, dextran, albumin and...

  • Low-molecular weight iron dextran and iron sucrose have similar comparative safety profiles in chronic kidney disease. Auerbach, M.; Al Talib, K. // Kidney International;Mar2008, Vol. 73 Issue 5, p528 

    Serious adverse events that occur with the administration of iron dextran are due to the high molecular weight preparations. Conclusions that iron sucrose and ferric gluconate are safer than iron dextran may be premature. Published literature comparing safety profiles of available parenteral...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics